リスリド

Lisuride

HCID 28864CAS 140387-89-9

基本情報

標準SMILES
CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
InChIKey
SORAZNWVQFKAFD-IBIFCFAISA-N
分子式
C20H26N4O
平均分子量
338.4 g/mol

概要

Lisuride is a monocarboxylic acid amide. It has a role as a serotonergic agonist, an antiparkinson drug, a dopamine agonist and an antidyskinesia agent. It derives from a hydride of an ergoline.

名称と識別子

優先名称
Lisuride
IUPAC
3-[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea
現地名
リスリド
英語名
S-(-)-LISURIDE
分子式
C20H26N4O
分子量
338.45

名称と別名

LISURIDELysuride18016-80-3LisuridaLisuridumDoperginN'-((8alpha)-9,10-Didehydro-6-methylergolin-8-yl)-N,N-diethylureaE0QN3D755ODTXSID3023217CHEBI:51164Methylergol CarbamideLysurid
名称をさらに表示
N'-(9,10-ジデヒドロ-6-メチルエルゴリン-8α-イル)-N,N-ジエチル尿素リスリドメチルエルゴルカルバミドN'-[(5β)-9,10-ジデヒドロ-6-メチルエルゴリン-8α-イル]-N,N-ジエチル尿素3-[(8α)-9,10-ジデヒドロ-6-メチルエルゴリン-8-イル]-1,1-ジエチル尿素N′-(9,10-ジデヒドロ-6-メチルエルゴリン-8α-イル)-N,N-ジエチル尿素N′-[(5β)-9,10-ジデヒドロ-6-メチルエルゴリン-8α-イル]-N,N-ジエチル尿素3,3-ジエチル-1-[(4S,7R)-6-メチル-6,11-ジアザテトラシクロ[7.6.1.02,7.012,16]ヘキサデカ-1(16),2,9,12,14-ペンタエン-4-イル]尿素LisuridCABERQOLINEMesorgydinePrestwick_525S-(-)-LISURIDELisuride (S)(-)(+)-(5R,8S)-Lisuride
Urea, N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethyl-3,3-diethyl-1-[(4S,7R)-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaen-4-yl]ureaMesylate, Lisuride3,3-diethyl-1-((4S,7R)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaen-4-yl)ureaRevanil 200Carbamide, MethylergolHydrochloride, LisurideRefChem:799371

データベース識別子

CAS
140387-89-9、18016-80-3
PubChem CID
28864
DTXSID
DTXSID3023217
ChEMBL
CHEMBL157138
ChEBI
CHEBI:51164
UNII
E0QN3D755O
EC Number
241-925-1
Nikkaji
J10.957F

物性

構造計算による物性

XLogP
2.7
極性表面積
51.4 Ų
水素結合供与体数
2
水素結合受容体数
2
回転可能結合数
3
重原子数
25

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LogP2.2
Solubility1.40e-01 g/L
Human DrugsBreast Feeding; Lactation; Antiparkinson Agents; Dopamine Agonists; Serotonin Receptor Agonists
Physical DescriptionSolid

物理化学的性質

融点
186 ° · 186°
比旋光度
20 · D20 +313° (c = 0.60 in pyridine)
沸点
603.4 · 603.4±55.0 °C(Predicted)
比重(密度)
1.23 · 1.23±0.1 g/cm3(Predicted)
酸解離定数(Pka)
13.06 · 13.06±0.20(Predicted)
外見
Solid

安全と法規制

GHS分類

GHS Classification · 4 件

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P260, P262, P264, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P316, P320, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 2 (100%)

毒性情報

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H300

化学と産業

薬理情報

ATC Code · 4 件

G - Genito urinary system and sex hormones

N - Nervous system

QG - Genito urinary system and sex hormones

QN - Nervous system

Protein Bindingabout 15%
PharmacodynamicsThere is evidence that lisuride lowers prolactin levels and, in low doses, prevents migraine attacks.
Mechanism of Action · 1 件

Lisuride is an anti-Parkinson drug chemically related to the dopaminergic ergoline Parkinson's drugs. Lisuride binds to the 5-HT(1A) and 5-HT(2A/2C) receptors. It is also thought to bind to the dopamine receptor and to act as a dopamine agonist. Evidence has also emerged that Lisuride also binds to the Histamine H1 receptor.

MeSH Pharmacological Classification · 3 件

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.

Drugs that bind to and activate dopamine receptors.

Cellular LocationsMembrane

サプライヤー6 社

中梦研(湖北)科技有限公司0717-6300888 18062399888 · [email protected]
Shaanxi Dideu New Materials Co. Ltd18192503167 · [email protected]
上海知邦生物医药有限公司021-54285032 18116461626 · [email protected]
湖南嘉航医药科技有限公司85567275 15200744171 · [email protected]
湖北凯隆生物科技有限公司19526384105 · [email protected]

関連反応

3 件

関連ノート

読み込み中…